Waud Capital Partners Acquires Science Exchange to Fuel Innovation in Life Sciences Supplier Orchestration Technology
illi News/10279735

CHICAGO, Sept. 30, 2024 ~ Chicago, IL - Waud Capital Partners, a private equity firm specializing in the software & technology and healthcare sectors, has announced its acquisition of Science Exchange. The leading provider of life sciences procurement and supplier management SaaS solutions marks a significant milestone in its journey with this partnership.

After conducting a thorough evaluation of the life sciences procurement technology market, Waud Capital identified Science Exchange as a standout leader. The company's innovative cloud supplier orchestration platform, delivered through a transparent SaaS subscription model, has gained traction among top global pharmaceutical companies and biotech organizations. Its platform digitizes procurement workflows and drives cost savings, streamlines supplier collaboration, and accelerates project execution.

"We are thrilled to have Waud Capital's support as we solidify our position as the premier SaaS supplier orchestration platform in the life sciences industry," said Elizabeth Iorns, Ph.D., CEO & Co-Founder of Science Exchange. "This partnership will enable us to accelerate our product innovation, drive even faster growth, and expand our impact across the industry."

More on illi News

• Artist Séfora Camazano Honored with Prestigious Prize "The New Great Masters in New York"
• MoMojo Records announces posthumous album from Kip London
• Guests Can Save 20 Percent on a Florida Keys Vacation Home Rental with KeysCaribbean's 'Last-Minute Booking Discount'
• All-Woman Trial Team Wins Major Verdict in Major Case
• Iohexol Injection of Beilu Pharmaceutical Receives MA in the EU

Waud Capital's proven track record in scaling technology companies and deep experience in healthcare and life sciences make them an ideal partner for Science Exchange's next phase of evolution. "This acquisition is a testament to the strength of Science Exchange's technology and leadership team," said Matthew Clary, Partner at Waud Capital.

Under Waud Capital's ownership, Science Exchange plans to expand its product portfolio, invest in innovative technologies, and elevate its market presence. Elizabeth Iorns will continue as CEO & Co-Founder alongside COO & Co-Founder Dan Knox and Chief Revenue Officer Tzlil Hadass.

Mark Layden will join the company as Executive Chairman under Waud Capital's ownership. "I am incredibly excited to join Science Exchange at this pivotal moment in its growth journey," said Mark Layden. "With Waud's backing and the strength of this talented leadership team, I am confident that Science Exchange will continue to set the standard for supplier orchestration."

Houlihan Lokey acted as financial advisor and Kirkland & Ellis LLP acted as legal counsel to Waud Capital. Union Square Advisors acted as financial advisor and Fenwick & West LLP acted as legal counsel to Science Exchange. The terms of the transaction were not disclosed.

---

Show All News | Report Violation